![Dominic Schmidt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dominic Schmidt
Private Equity Investor bei
Advent Venture Partners LLP
Profil
Dr. Dominic Schmidt is a General Partner at Advent Venture Partners LLP.
Dr. Schmidt was previously employed as a Non Executive Director by Forcefield Therapeutics Ltd., a Non Executive Director by Anaveon AG, a Non-Executive Director by Gyroscope Therapeutics Ltd., a Non-Executive Director by Orbit Biomedical, Inc., a Partner by Syncona Partners LLP, and an Associate by L.E.K.
Consulting Group Ltd. He also served on the board at Purespring Therapeutics Ltd., Orbit Biomedical Ltd. and Freeline Therapeutics Ltd.
He received his undergraduate degree from Freie Universität Berlin, a graduate degree from Freie Universität Berlin and a doctorate degree from the University of Cambridge.
Aktive Positionen von Dominic Schmidt
| Unternehmen | Position | Beginn |
|---|---|---|
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Private Equity Investor | 01.04.2022 |
Ehemalige bekannte Positionen von Dominic Schmidt
| Unternehmen | Position | Ende |
|---|---|---|
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Private Equity Investor | 01.03.2022 |
Anaveon AG
 Anaveon AG BiotechnologyHealth Technology Develops biologics for cancer | Direktor/Vorstandsmitglied | 01.03.2022 |
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Direktor/Vorstandsmitglied | 01.03.2022 |
Forcefield Therapeutics Ltd.
 Forcefield Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics to retain heart function via protection of cardiomyocytes | Direktor/Vorstandsmitglied | 01.03.2022 |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Direktor/Vorstandsmitglied | 01.02.2022 |
Ausbildung von Dominic Schmidt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Finance |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Freie Universität Berlin
 Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Finance |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which developing gene therapies for bleeding and other debilitating disorders | Health Technology |
Orbit Biomedical, Inc.
 Orbit Biomedical, Inc. Medical SpecialtiesHealth Technology Develops surgical devices | Health Technology |
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Develops biologics for cancer | Health Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Health Technology |
L.E.K. Consulting Group Ltd.
 L.E.K. Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services Provides global strategy consulting services | Commercial Services |
Orbit Biomedical Ltd.
 Orbit Biomedical Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology | Commercial Services |
Purespring Therapeutics Ltd.
Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Health Technology |
Forcefield Therapeutics Ltd.
Forcefield Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics to retain heart function via protection of cardiomyocytes | Health Technology |
